Dosage Optimization of Nemolizumab Using Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Modeling and Simulation.

about

Dosage Optimization of Nemolizumab Using Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Modeling and Simulation.

Item

http://www.wikidata.org/entity/Q48722683

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Dosage Optimization of Nemoliz ...... namic Modeling and Simulation.

@en

Dosage Optimization of Nemoliz ...... namic Modeling and Simulation.

@nl

type

Item

label

Dosage Optimization of Nemoliz ...... namic Modeling and Simulation.

@en

Dosage Optimization of Nemoliz ...... namic Modeling and Simulation.

@nl

prefLabel

Dosage Optimization of Nemoliz ...... namic Modeling and Simulation.

@en

Dosage Optimization of Nemoliz ...... namic Modeling and Simulation.

@nl

P1476

Dosage Optimization of Nemoliz ...... namic Modeling and Simulation.

@en

P2093

Kimio Terao

http://www.w3.org/2001/XMLSchema#string

Satofumi Iida

http://www.w3.org/2001/XMLSchema#string

Tomohisa Saito

http://www.w3.org/2001/XMLSchema#string

Yuji Kumagai

http://www.w3.org/2001/XMLSchema#string

P2860

IL-31: a new link between T cells and pruritus in atopic skin inflammation

IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models.

Mixed-effects beta regression for modeling continuous bounded outcome scores using NONMEM when data are not on the boundaries.

Population PK/PD modeling of eltrombopag in healthy volunteers and patients with immune thrombocytopenic purpura and optimization of response-guided dosing.

Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease.

Itch and atopic dermatitis: an overview.

Combining patient-level and summary-level data for Alzheimer's disease modeling and simulation: a β regression meta-analysis.

Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.

P304

1564-1572

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCPH.969

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28703903

http://www.w3.org/2001/XMLSchema#string